BAAM
EGRX

Baker Avenue Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Baker Avenue Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15
Closed -$426 – 1767
2023
Q1 		$426 Buy
+15
New +$426 ﹤0.01% 1491